"Designing Growth Strategies is in our DNA"
Breast reconstruction refers to a surgical procedure where new breast shape or mound is created using surgeries. Breast reconstruction may be undertaken either after the procedure of mastectomy (where the complete breast is removed, sometimes also associated lymph nodes & muscles) or after the procedure of breast conservation (where only parts of the breast are removed). Breast reconstruction is often undertaken to restore the symmetry of the breasts and the process can be started right after the mastectomy (immediate reconstruction) or after some time of the mastectomy (delayed reconstruction). The decisions regarding the breast reconstruction will be based on a multitude of factors such as overall health, the status of cancer treatment, body type, the advantages & disadvantage of each option and the lifestyle of the individual. Breast reconstruction involves a number of possible complications such as pain, poor incision healing, anesthesia issues and the formation of scar tissues.
Increasing emphasis on aesthetic appearance is prominently expected to boost the demand for the global breast reconstruction market during the forecast period. Combined with this, increasing the prevalence of breast cancer, increasing incidences of obesity, and increasing awareness of breast reconstruction surgeries are projected to drive the market by 2026. According to study results published by The American Cancer Society, the individuals who have breast-conserving reconstruction surgery followed by radiation therapy have lesser chances of the recurrence of cancer and greatly improved survival rates.
To gain extensive insights into the market, Request for Customization
The factors limiting the growth of the global breast reconstruction market includes the possibility of occurrence of secondary cancers and complication such as ruptures or deflations. Additionally, the high cost of surgical procedures is also expected to restrain the growth of the global breast reconstruction market during the forecast period.
Some of the major companies that are present in the global breast reconstruction market are ALLERGAN, Mentor Worldwide LLC, Sientra, Inc., GC Aesthetics, GROUPE SEBBIN SAS, POLYTECH Health & Aesthetics GmbH and Establishment Labs S.A.
SEGMENTATION | DETAILS |
By Product | · Breast Implants · Tissue Expanders · Acellular Dermal Matrix (ADM) · Others |
By Placement | · Submuscular Insertion · Subglandular Insertion · Dual-Plane Insertion |
By End User | · Hospitals · Clinics · Ambulatory Surgery Centres · Others |
By Geography | · North America (USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa) |
Among the segmentation, breast implants in the product segment are expected to hold a significant share of the market due to the higher number of implant procedure being conducted across the globe.
North America is expected to hold a significant share in the global breast reconstruction market owing to the rising number of breast reconstruction surgeries and a rising emphasis on aesthetic appearance. Moreover, increasing prevalence of cancer, as well as obesity, is projected to propel the adoption of breast reconstruction surgeries during the forecast period. According to the American Society of Plastic Surgeons, breast augmentation was the top surgery performed under cosmetic procedures category in the U.S. in 2017. Asia Pacific is anticipated to register higher CAGR owing to developing healthcare infrastructure, increasing awareness about breast reconstruction surgeries amongst women and increasing per capita expenditure in emerging countries.
US +1 833 909 2966 ( Toll Free )